Transcatheter aortic valve replacement: Flattening the cost curve

JAMA

Volumn 312, Issue 1, 2014, Pages 25-26

  Feldman, Arthur M ^a   DiSesa, Verdi J ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA VALVE PROSTHESIS; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; CEREBROVASCULAR ACCIDENT; COMPARATIVE EFFECTIVENESS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DEVICE APPROVAL; ENDOLEAK; HEALTH CARE COST; HEALTH CARE DISPARITY; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK BENEFIT ANALYSIS; SHORT SURVEY; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME;

AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; COST CONTROL; COST-BENEFIT ANALYSIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PATIENT SELECTION; QUALITY OF HEALTH CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGISTRIES; REIMBURSEMENT MECHANISMS; UNITED STATES;

EID: 84903633625     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.4606     Document Type: Short Survey

References (8)

1. Brennan JM, Edwards FH, Zhao Y, et al; DECIDE AVR (Developing Evidence to Inform Decisions About Effectiveness-Aortic Valve Replacement) Research Team. Long-term safety and effectiveness of mechanical vs biologic aortic valve prostheses in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database. Circulation. 2013;127(16):1647-1655.
2. Holmes DR Jr, Mack MJ, Kaul S, et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol. 2012;59(13):1200-1254.
3. Smith CR, Leon MB, Mack MJ, et al; PARTNER Trial Investigators. Transcatheter vs surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187-2198.
4. Abdel-Wahab M, Zahn R, Horack M, et al; German Transcatheter Aortic Valve Interventions Registry Investigators. Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Heart. 2011;97(11):899-906.
5. Gurvitch R, Tay EL, Wijesinghe N, et al. Transcatheter aortic valve implantation: lessons from the learning curve of the first 270 high-risk patients. Catheter Cardiovasc Interv. 2011;78(7):977-984.
6. Simons CT, Cipriano LE, Shah RU, Garber AM, Owens DK, Hlatky MA. Transcatheter aortic valve replacement in nonsurgical candidates with severe, symptomatic aortic stenosis: a cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes. 2013;6(4):419-428.
7. Doble B, Blackhouse G, Goeree R, Xie F. Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: a Canadian perspective. J Thorac Cardiovasc Surg. 2013;146(1):52-60, e3.
8. Mack MJ, Brennan JM, Brindis R, et al; STS/ACC TVT Registry. Outcomes following transcatheter aortic valve replacement in the United States. JAMA. 2013;310(19):2069-2077.